[PDF] Top 20 Moderated Posters: Prostate Cancer

... tant prostate cancer (CRPC) and prostate-specific antigen doubling time (PSADT) of approximately ≤6 months are in the top tier of risk for PC progression to bone, reflecting an important high-risk ... See full document

... Methods: A decision model was developed to simulate the management of PCa from diagnosis to end-of-life. Health states modeled by risk at diagnosis were - active surveillance (AS), initial treatments (radical pros- ... See full document

... Methods: We performed a single-centre, phase II, open-label trial in which men with LHRH agonist-related fatigue were given 2 daily cans of Red Bull® Sugar-Free energy drinks for a period of 4 weeks. Fatigue levels were ... See full document

... The Mount Sinai Medical Center, New York, NY, United States Introduction and Objectives: Active surveillance (AS) is a suitable option for many patients with low risk prostate cancer (PCa) that relies on ... See full document

... following prostate biopsy can be associated with significant morbidity and occasional ...for prostate biopsy from oral ciprofloxacin alone to a combination of single- dose ciprofloxacin and ... See full document

... 7, 254 men in the CaPSURE registry diagnosed between 1998 and 2005 were analyzed. Treatment was categorized as local alone, primary ADT, local treatment with ADT (neoadjuvant/adjuvant or salvage) and watchful waiting/ ... See full document

... with prostate cancer and scheduled for radical prostatectomy under- went real time elastography and contrast enhanced MRI before radical prostatectomy at least 6 weeks after prostate biopsy by ... See full document

... Results: Key expectation and educational domain data included 45% of men responding that they did not have clear idea of SEs to be expected; 17% and 27% of men, respectively, reported emotional and physical SEs worse ... See full document

... to prostate cancer (PCa), and have great potential for noninvasive diagnosis and prognosis of prostate cancer in patients’ bodily flu- ... See full document

... and cancer-specific survival rate was ...low-risk prostate cancer on active surveil- lance, the first positive repeated biopsy showed significant hazard for pathological disease ... See full document

... pelvic cancer in the absence of unresectable distant disease were ...recurrent cancer, 3 were alive with disease recurrence, and 17 had no evidence of ... See full document

... localized prostate cancer ...localized prostate cancer at the VA Medical Centers, to investigate the changes in the pattern of care that may have occurred over time, and to compare treatment ... See full document

... Jeldres Claudio, Sun Maxine, Ismail Salima, Morgan Monica, Liberman Daniel, Johal Rupinder, Abdo Al’a, Perrotte Paul, Karakiewicz Pierre I Department of Urology, University of Montreal, Montreal, QC, Canada Introduction ... See full document

... Methods: We analyzed a cohort of 117 patients treated with permanent seed brachytherapy for localized prostate cancer. Adipose tissue distribu- tion was measured on computed tomography (CT) images at four ... See full document

... on prostate cancer survival out- comes are complicated by variation in patient populations and study outcomes in most retrospective ...Ontario Cancer Registry (OCR) and supplemented through an ... See full document

... Introduction and Objectives: Salvage high intensity focused ultrasound (s-HIFU) is a minimally invasive potentially curative therapeutic option for locally radio-recurrent prostate cancer (rr-PCa), when ... See full document

... Methods: Using Surveillance, Epidemiology, End Results data linked to Medicare records, we identified patients with high risk, bladder cancer, who were diagnosed from 2004-2005 with follow-up through 2007. High ... See full document

... bladder cancer in Ontario undergoing cys- tectomy from 1994-2008 were identified in the Ontario Cancer ...and cancer specific survival (CSS) were estimated using the Kaplan-Meier ...of ... See full document

... Introduction and Objectives: Renal Cell Carcinoma (RCC) exhibits a met- abolic phenotype known as the Warburg Effect. This principle describes the preferential usage of cytoplasmic glycolysis (Gly) over mitochondrial ... See full document

... Introduction and Objectives: Recently, the SWI/SNF chromatin remod- eling complex gene PBRM1 was identified as the second major cancer tumor suppressor gene in clear cell renal cell carcinoma (ccRCC), with ... See full document